Europe Diagnostic Controls Market is expected to grow with the CAGR of 8.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-molecular-diagnostic-controls-market
Europe diagnostic controls market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Europe diagnostic controls market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
Bio-Rad Laboratories Inc. is a dominating player in Europe Diagnostic controls market. The other key players existing in the market includes Randox Lanoratories Ltd., Technopath Clinical Diagnostics, Thermo Fisher Scientific Inc., Abbott, and bioMérieux SA among others.
Bio-Rad Laboratories Inc. has it base headquarters in California, U.S. and was founded in 1952. The company is focused in development, manufacturing, and marketing of broad range of innovative product for the life science research and clinical diagnostics market. The company deals in two business segment life science and clinical diagnostic. The company deals in Product portfolio such as life science research, clinical diagnostics, process separators and food science out of which clinical diagnostics is the market focused product portfolio.
The company has presence in North America, Latin America, Europe, Asia-Pacific. The company has its base subsidiaries in Bio-Rad Korea (Korea), Bio-Rad laboratories S.r.l. (Italy), Bio-Rad S.A (Canada), Bio-Rad Laboratories GmbH (Germany), Bio-Rad Laboratories (India) among others.
Randox Laboratories Ltd.
Randox Laboratories Ltd. is headquartered in Antrim, U.K. and was founded in 1982. The company is focused on the development of prioneering tests for a range of common illness such as cancer, cardiovascular disease and alzheimer’s disease. The company has multiple product categories such as clinical chemistry, analysers, molecular, reagents, quality control, EQA, Veterinary, immunoassay, biosciences and disease markers out of which quality control are the market focused category.
The company has wide global presence across America, Europe.
Technopath Clinical Diagnostics
Technopath clinical diagnostics is headquartered in Tipperary, Ireland and was founded in 2004. The company is engaged in the development and manufacturing of quality control material and software for clinical laboratories. The company offers wide range of product categories such as quality control materials, informatics solutions and other products. The market focused category is quality control materials.
The company has wide global presence across the world in Americas, Europe.
Europe Molecular Diagnostic Controls Market – Industry Trends and Forecast to 2028
Africa Molecular Diagnostic Controls Market – Industry Trends and Forecast to 2028
India Molecular Diagnostic Controls Market – Industry Trends and Forecast to 2028